Group by:
Date |
Item TypeArticle
The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts.
Behrens, D. and Lykkesfeldt, A.E. and Fichtner, I.
Targeted Oncology 2
(3): 135-144.
July 2007
Review
The role of biologics in stomach cancer.
Lordick, F. and Schulze, T. and Jaeger, D.
Targeted Oncology 3
(2): 71-79.
April 2008
This list was generated on Tue May 7 02:32:07 2024 CEST.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
